The results of a Phase III randomized clinical trial have shown that when it comes to detecting clinically significant prostate cancer, Magnetic Resonance Imaging (MRI) with targeted biopsies (MRI-TBx ...
The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major advancement in image-guided navigation for prostate cancer care with ...
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage innovator in interventional MRI (“iMRI”) procedures, is ...
Here's welcome news for men of a certain age: new results support a less invasive approach to investigations for suspicion of prostate cancer. An approach using MRI of the prostate followed by ...
Please provide your email address to receive an email when new articles are posted on . Combining an MRI-targeted biopsy approach with the Stockholm3 blood test for prostate cancer screening reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results